New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
287.21-3.04 (-1.05%)
At close: 04:00PM EDT
285.01 -2.20 (-0.77%)
After hours: 04:06PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,605,238
2,671,262
2,802,249
2,922,545
2,545,626
Cost of revenue
1,214,743
1,244,316
1,234,919
1,284,449
1,107,739
Gross profit
1,390,495
1,426,946
1,567,330
1,638,096
1,437,887
Operating expenses
Research development
238,851
247,427
256,889
260,638
217,763
Selling general and administrative
831,053
841,723
827,825
877,122
798,798
Total operating expenses
1,069,904
1,089,150
1,092,214
1,137,760
1,016,561
Operating income or loss
320,591
337,796
475,116
500,336
421,326
Interest expense
49,379
49,439
38,114
1,551
21,861
Total other income/expenses net
-799,695
-1,239,404
-5,199,249
4,931,395
4,500,354
Income before tax
-443,855
-850,104
-4,704,273
5,449,055
4,918,007
Income tax expense
-121,485
-212,780
-1,076,738
1,194,798
1,103,778
Income from continuing operations
-322,370
-637,324
-3,627,535
4,254,257
3,814,229
Net income
-322,370
-637,324
-3,627,535
4,254,257
3,814,229
Net income available to common shareholders
-322,370
-637,324
-3,627,535
4,254,257
3,814,229
Basic EPS
-6.01
-21.82
-121.79
142.61
128.13
Diluted EPS
-6.01
-21.82
-121.79
140.83
126.47
Basic average shares
29,433
29,209
29,785
29,831
29,768
Diluted average shares
29,433
29,209
29,785
30,208
30,160